Skip to Content
 
International Parkinson and Movement Disorder Society

Scales for Outcomes in Parkinson’s Disease – Psychosocial Functioning (SCOPA-PS)

A self-administered, 11-item questionnaire assessing psychosocial functioning during the preceding month.

Permission is required for each single use of the MDS Clinical Outcome Assessments. 

Request permission   View more assessments

The SCales for Outcomes in PArkinson’s disease- Psychosocial Functioning (SCOPA-PS) is a self-administered, 11-item questionnaire assessing psychosocial functioning during the preceding month, on a scale ranging from 0 (not at all) to 3 (very much). A summary index is calculated by transformation of the items sum score into a percentage of the maximum possible score (33 points). The higher the summary index, the worse the psychosocial functioning.

The development of the SCOPA-PS is part of a larger research project, the SCales for Outcomes in PArkinson’s disease (SCOPA), in which practical and clinimetric sound instruments for all relevant regions in PD are selected or developed. The SCOPA instruments were originally developed in the Dutch language. 

Authors: Marinus J, Visser M, Martínez-Martín P, van Hilten JJ, Stiggelbout AM

Original Publication │ View the Scale (PDF) Permission required for use  

  • Acronym: SCOPA-PS
  • Year Published: 2003
  • Last Updated: Unchanged since publication
  • Instrument Type: PRO
  • Estimated Time to Complete: 5-10 minutes

 Available translations: 5 languages

  Eletronic builds: REDCap


To request permission to use this Rating Scale, please fill out a Permission Request Form.

Request Permission

 

 

Available Translations

Inclusive Language in Clinical Outcome Assessments

Healthcare providers should tailor the language used in COAs to reflect each patient’s gender identity. In grammatically gendered languages, the practice includes making appropriate linguistic adjustments to ensure communication is respectful and inclusive throughout the assessment process.

 

Related Publications

Virués‐Ortega J, Carod‐Artal FJ, Serrano‐Dueñas M, Ruiz‐Galeano G, Meza‐Rojas G, Velázquez C, Micheli F, Martínez‐Martín P. Cross‐Cultural Validation of the Scales for Outcomes in Parkinson's Disease‐Psychosocial Questionnaire (SCOPA‐PS) in Four Latin American Countries. Value in Health.Movement Disorders. 2009 Feb; 12(2): 385- 381.

Carod-Artal  FJ, Martinez-Martin  P, Vargas  AP. Independent validation of SCOPA–psychosocial and metric properties of the PDQ‐39 Brazilian version. Movement Disorders. 2007 Jan; 22(1): 91-98.

Fereshtehnejad SM, Farhadi F, Hadizadeh H, Shahidi GA, Delbari A, Lökk J. Cross-cultural validity, reliability, and psychometric properties of the persian version of the scales for outcomes in Parkinson's disease-psychosocial questionnaire. Neurol Res Int. 2014;2014:260684

Martínez-Martín P, Carroza-García E, Frades-Payo B, Rodríguez-Blázquez C, Forjaz MJ, de Pedro-Cuesta J; Grupo ELEP  [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review]. Rev Neurol. 2009 Jul 1-15;49(1):1-7. Spanish.

Martínez-Martin P, Carod-Artal FJ, da Silveira Ribeiro L, Ziomkowski S, Vargas AP, Kummer W, Mesquita HM. Longitudinal psychometric attributes, responsiveness, and importance of change: An approach using the SCOPA-Psychosocial questionnaire. Mov Disord. 2008 Aug 15;23(11):1516-23.

Browse all 30+ movement disorder assessments

View scales